Skip to content
POM-V Prescription Required Companion Animal

Selgian 10 mg Film-Coated Tablets

Active ingredient: Selegiline Hydrochloride

Form

Tablet

Species

Dogs

Manufacturer

Ceva Sante Animale

VMD MA No.

14966/4001

What it's used for

- origin observed in behavioural conditions such as over activity, separation problems, generalised phobia and unsociable behaviour. Emotional disorders ar...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Selegiline Hydrochloride

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Selgian 10 mg Film-Coated Tablets — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

-
origin observed in behavioural conditions such as over activity,
separation problems, generalised phobia and unsociable behaviour.
Emotional disorders are characterised by a modification of feeding, drinking, auto-
stimulatory behaviour, sleep, exploratory behaviour, aggression related to fear and/or
irritation, social behaviour and somatic disorders (tachycardia, emotional micturition).
Dog weight in kgNumber of tablets≥ ½≥< 17¾≥< 221≥< 271 ¼≥< 321 ½≥< 371 ¾≥< 422
For dogs weighing more than 8 kg, use Selgian

4 mg.
The treatment should be continued until the clinical condition is stable.
The minimum treatment period recommended is 2 months, based on the clinical
trials results:
- The treatment period was 2 to 3 months for 20 % of the dogs
- The treatment period was 4 to 5 months for 50 % of the dogs
- The treatment period was 6 to 7 months for 20 % of the dogs
- The treatment period was > 7 months for 10 % of the dogs
The treatment can be stopped suddenly without gradual dose reductions.
Owing to its IMAO properties, (–) selegiline hydrochloride may act on prolactin
secretion. In the absence of specific studies, it is recommended that the product
should not be administered to pregnant and lactating bitches.
Do not administer the product from the day before until the day after anaesthesia
or tranquillisation performed with an alpha-2 agonist.
Do not administer the product concomitantly with pethidine, fluoxetine or

phenothiazines.
The narcotic action of morphine is potentiated by the product.
Dogs:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Behavioural disorders
Trials have shown that some dominant dogs, with behavioural disorders but no
signs of aggression, may become aggressive after treatment. Those previously
showing aggression may have this enhanced. Appropriate training is essential in
such cases.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.
If no clinical improvement is observed after 2 months, continuing the treatment is not
likely to provide any additional benefit.
It is advisable to weigh animals before dosing to ensure the correct mg/kg dosage is
administered.

Special precautions for safe use in the target species:
Emotional disorders can mask hierarchical conflicts. In dominant dogs suffering
from an emotional disorder, the alleviation of the disorder can sometimes reveal a
latent aggressiveness. In such cases, behavioural therapy must be instituted.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In the event of accidental ingestion, seek medical advice immediately and show
the package leaflet or the label to the physician.
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.
Do not administer the product from the day before until the day after an anaesthesia
or tranquillisation performed with an alpha-2 agonist.
Do not administer the product concomitantly with pethidine, fluoxetine or
phenothiazines.
The narcotic action of morphine is potentiated by the product.
Do not store above 25°C.
The tablets are divisible into quarters. Tablet portions can be kept for 4 days in the
blister packs.
Not applicable

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance
Same active ingredient

Other Products Containing Selegiline Hydrochloride

These products share the same active ingredient and may be suitable alternatives. Always consult your vet.

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.